A novel cytotoxic cerium complex: Aquatrichloridobis(1,10-phenanthroline) cerium(III) (KP776). Synthesis, characterization, behavior in H2O, binding towards biomolecules, and antiproliferative activity

Chemistry and Biodiversity

Volumn 6, Issue 12, 2009, Pages 2153-2165

  Biba, Florian ^a   Groessl, Michael ^a,b   Egger, Alexander ^a   Jakupec, Michael A ^a   Keppler, Bernhard K ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b EPFL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; AQUATRICHLORIDOBIS(1,10 PHENANTHROLINE)CERIUM; KP 776; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CAPILLARY ELECTROPHORESIS; CARBON NUCLEAR MAGNETIC RESONANCE; CELL PROLIFERATION; CYTOTOXICITY; DRUG ANALYSIS; DRUG BIOAVAILABILITY; DRUG INHIBITION; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; PROTON NUCLEAR MAGNETIC RESONANCE;

ANTINEOPLASTIC AGENTS; BLOOD PROTEINS; CELL LINE, TUMOR; CERIUM; DRUG SCREENING ASSAYS, ANTITUMOR; ELECTROPHORESIS, CAPILLARY; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; ORGANOMETALLIC COMPOUNDS; PROTEIN BINDING; SPECTROPHOTOMETRY, INFRARED; TEMPERATURE; TIME FACTORS; WATER;

EID: 74549190949     PISSN: 16121872     EISSN: 16121880     Source Type: Journal    
DOI: 10.1002/cbdv.200900011     Document Type: Article

References (27)

1. S. P. Fricker, Chem. Soc. Rev. 2006, 35, 524.
2. C. H. Evans, in 'Biochemistry of the Elements, Biochemistry of the Lanthanides', Ed. E. Frieden, Plenum Press, New York, 1990, Vol. 8.
3. T. Sato, M. Hashizume, Y. Hotta, Y. Okahata, BioMetals 1998, 11, 107.
4. L. J. Anghileri, Eur. J. Cancer 1979, 15, 1459.
5. M. A. Jakupec, P. Unfried, B. K. Keppler, Rev. Physiol. Biochem. Pharmacol. 2005, 152, 101.
6. C. Lewin, Med. Klin. 1924, 20, 1319.
7. B. Cohn, Dtsch. Med. Wochenschr. 1925, 51, 1984.
8. T. Sato, M. Hushizume, Y. Hotta, Y. Okahata, Biometals 1998, 11, 107.
9. P. G. Sammes, G. Yahioglu, Chem. Soc. Rev. 1994, 23, 327.
10. K. H. Falchuk, A. Krishan, Cancer Res. 1977, 37, 2050.
11. C. Krishnamurti, L. A. Saryan, D. H. Petering, Cancer Res. 1980, 40, 4092.
12. B. K. Keppler, Faustus Forschungs Cie. Translational Cancer Research G.m.b.H. Germany, Pat. WO2003014128, 2003.
13. M. A. Jakupec, V. Arion, W. Berger, S. Wild, H. Zorbas, B. K. Keppler, Eur. J. Cancer 2002, 38 (Suppl. 78), S125.
14. P. Heffeter, M. A. Jakupec, W. Kçrner, S. Wild, N. G. von Keyserlingk, L. Elbling, H. Zorbas, A. Korynevska, S. Knasmueller, H. Suttertuetty, M. Miksche, B. K. Keppler, W. Berger, Biochem. Pharmacol. 2006, 71, 426.
15. P. Heffeter, M. A. Jakupec, W. Kçrner, P. Chiba, C. Pirker, R. Dornetshuber, L. Elbling, H. Sutterluetty, M. Miksche, B. K. Keppler, W. Berger, Biochem. Pharmacol. 2007, 73, 1873.
16. V. Dolník, Electrophoresis 2008, 29, 143.
17. C. G. Hartinger, B. K. Keppler, Electrophoresis 2007, 28, 3436.
18. N. H. Bings, A. Bogaerts, J. A. C. Broekaert, Anal. Chem. 2008, 80, 4317.
19. F. A. Hart, F. P. Laming, J. Inorg. Nucl. Chem. 1964, 26, 579.
20. A. A. Schilt, R. C. Taylor, J. Inorg. Nucl. Chem. 1959, 9, 211.
21. K. Iftikhar, Polyhedron 1996, 15, 1113.
22. K. Nakamoto, 'Infrared and Raman Spectra of Inorganic and Coordination Compounds', John Wiley & Sons, New York, 1978.
23. I. Nakagawa, T. Shimanouchi, Spectrochim. Acta 1964, 20, 429.
24. 'Guideline on Impurities in New Drug Substances', International Conference on Harmonization, Federal Register, Government Printing Office,Washington, DC, 1996, p. 372.
25. S. Curry, Vox Sang. 2002, 83 (Suppl. 1), 315.
26. P. T. Gomme, K. B. McCann, J. Bertolini, Drug Discovery Today 2005, 10, 267.
27. C. G. Hartinger, S. Zorbas-Seifried, M. A. Jakupec, B. Kynast, H. Zorbas, B. K. Keppler, J. Inorg. Biochem. 2006, 100, 891.